Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 1 | / | 2022 | |||||||||
| Data sporządzenia: | 2022-01-07 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Commencement of sales of CompuFlo® Epidural disposables within prominent pain clinic with leading physician | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that Dr. Harsh Govil, MD, MPH, whose practice is based in Statesville, NC, has begun incorporating the CompuFlo® Epidural instrument into his practice for pain management, following a successful evaluation. Dr. Govil plans to utilize the CompuFlo Epidural instrument for office-based procedures to safely and quickly access the epidural space. The instrument provides real-time feedback and confirmation of epidural placement, which offers a number of advantages in terms of safety and efficacy. Dr. Harsh Govil joined Piedmont HealthCare as a non-surgical spine specialist offering the latest, most advanced techniques available for pain management. Dr. Govil is certified by the American Board of Physical Medicine with subspecialty certification in pain medicine. Piedmont HealthCare is one of the largest physician-owned multi-specialty groups in North Carolina and the Southeast in the U.S. committed to providing excellent care for the whole family. Piedmont has more than 60 convenient locations and nearly 200 physicians and providers across multiple specialties to provide the most innovative medical care for the community. The Board of Directors of the Company is pleased to announce that another leader in the field of pain management has incorporated the CompuFlo Instrument into his pain practice at a nationally recognized institution. The Board of Directors of the Company believes the use of the technology by Dr. Govil illustrates the commitment to patient safety, and incorporates the latest technologies to improve the patient experience. As indicated previously, the Board of Directors of the Company is excited to expand beyond labor and delivery into the pain management market. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2022-01-07 | Keisha Harcum | Controller | Keisha Harcum | ||
Źródło:Komunikaty spółek (ESPI)
